Generics
Accord Healthcare introduces Dehydrated Alcohol Injection for cardiovascular indications
26 June 2025 - Accord Healthcare Inc, a US-based generic pharmaceutical company, announced on Wednesday that it has added Dehydrated Alcohol Injection to its line of cardiovascular drugs.Accord's...
CivicaScript introduces low-cost multiple sclerosis treatment
25 June 2025 - CivicaScript LLC, a Utah-based nonprofit company involved in bringing low-cost generic medicines to US patients, announced on Tuesday the availability of dimethyl fumarate delayed-relea...
Breckenridge Pharmaceutical's generic for Ablysinol granted final FDA approval
25 June 2025 - Breckenridge Pharmaceutical Inc, the US subsidiary of Spain-based Towa International that markets, distributes and sells generic medicines in the United States, announced on Tuesday tha...
Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)
17 June 2025 - Glenmark Therapeutics Inc USA announced on Monday the launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), a generic version of Pataday Once Daily Relief.The antihis...
AB Science secures Canadian patent for AB8939, completing global IP coverage for AML treatment
12 June 2025 - French pharmaceutical company AB Science (Euronext Paris:AB) announced on Thursday that it has been granted a Canadian patent (CA 2975644) covering the composition of matter of AB8939 a...
Avera joins Civica to help maintain drug supplies
29 May 2025 - Non-profit generic pharmaceutical company Civica announced on Wednesday that Avera, a nonprofit healthcare provider in the Upper Midwest United States, has joined the company in helping ...